Inflammatory Bowel Disease Clinical Trials

A listing of Inflammatory Bowel Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

MMG
Birmingham Alabama 35294

We’re looking at Ulcerative Colitis from a different perspective.

MMG
Dothan Alabama 36305

We’re looking at Ulcerative Colitis from a different perspective.

View More ▼

Dothan Alabama 36305

A clinical trial to evaluate treatments using Apremilast and Placebo for patients with Ulcerative Colitis

Huntsville Alabama 35802

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Arizona

Phoenix Arizona

A Phase 2 clinical study for patients with Active, Moderate to Severe Crohn's Disease

Phoenix Arizona

A Phase 4 clinical study for patients with Inflammatory Bowel Disease

Scottsdale Arizona 85260

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85724

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85712

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

View More ▼

Tucson Arizona 85741

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Tucson Arizona 85712

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Arkansas

Little Rock Arkansas 72205

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Little Rock Arkansas 72211

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

North Little Rock Arkansas 72117

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

North Little Rock Arkansas 72117

A clinical trial seeking patients for a research study for the treatment of Crohn's Disease, Mild to Moderate

Sherwood Arkansas 72120

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

California

Bakersfield California 93301

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Garden Grove California 92845

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

La Jolla California 92037

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

La Mirada California 90638

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Laguna Hills California 92653

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

View More ▼

Los Angeles California 90067

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Los Angeles California 90045

A clinical trial to evaluate treatments using Apremilast and Placebo for patients with Ulcerative Colitis

Los Angeles California 90045

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Mission Hills California 91345

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Northridge California 91324

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Oceanside California 92056

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Orange California 92868

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Palo Alto California 94304

Patients are needed to participate in a clinical research study evaluating fecal calprotectin level for the treatment of Inflammatory Bowel Disease or Irritable Bowel Syndrome (IBS)

Rialto California 92377

A clinical trial seeking patients for a research study for the treatment of Crohn's Disease

San Carlos California 94070

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

San Diego California 92103

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Torrance California 90503

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Colorado

MMG
Wheat Ridge Colorado 80033

We’re looking at Ulcerative Colitis from a different perspective.

View More ▼

Denver Colorado 80045

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Littleton Colorado 80120

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Lone Tree Colorado

A Phase 2 clinical study for patients with Active, Moderate to Severe Crohn's Disease

Connecticut

Bristol Connecticut 06010

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Bristol Connecticut 06010

A clinical trial to evaluate treatments using Apremilast and Placebo for patients with Ulcerative Colitis

Danbury Connecticut 06810

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Hartford Connecticut

A Phase 4 clinical study for patients with Inflammatory Bowel Disease

Florida

NEW

Advanced Pharma - Miami
Miami Florida 33147

Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD

MMG
Hollywood Florida 33021

We’re looking at Ulcerative Colitis from a different perspective.

MMG
Naples Florida 34102

We’re looking at Ulcerative Colitis from a different perspective.

MMG
Orlando Florida 32806

We’re looking at Ulcerative Colitis from a different perspective.

MMG
Port Orange Florida 32127

We’re looking at Ulcerative Colitis from a different perspective.

MMG
Sweetwater Florida 33172

We’re looking at Ulcerative Colitis from a different perspective.

View More ▼

Boca Raton Florida 33428

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Boynton Beach Florida 33426

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease